| Vivimed Labs Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532660 |
NSE Symbol : VIVIMEDLAB |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE526G01021 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : 0.92 |
Market Cap(₹Cr) : 62.93 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 18.66 | 17.94 | 22.58 | 34.23 | 22.16 | 24.64 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 18.66 | 17.94 | 22.58 | 34.23 | 22.16 | 24.64 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.16 | 0.36 | 4.15 | 0.00 | 0.03 | 0.00 |
| Total Income | 18.82 | 18.30 | 26.73 | 34.24 | 22.19 | 24.64 |
| Total Expenditure | 19.98 | 18.48 | 25.06 | 34.41 | 22.95 | 35.71 |
| PBIDT | -1.16 | -0.18 | 1.67 | -0.18 | -0.76 | -11.07 |
| Interest | 1.60 | 0.52 | 1.48 | 0.43 | 0.37 | 0.25 |
| PBDT | -2.76 | -0.70 | 0.20 | -0.61 | -1.13 | -11.32 |
| Depreciation | 4.68 | 4.80 | 4.61 | 6.37 | 3.86 | 3.79 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -7.45 | -5.50 | -4.42 | -6.97 | -4.99 | -15.11 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -7.45 | -5.50 | -4.42 | -6.97 | -4.99 | -15.11 |
| EPS (Unit Curr.) | -0.90 | -0.66 | -0.53 | -0.84 | -0.60 | -1.82 |
| EPS (Adj) (Unit Curr.) | -0.90 | -0.66 | -0.53 | -0.84 | -0.60 | -1.82 |
| Calculated EPS (Unit Curr.) | -0.90 | -0.66 | -0.53 | -0.84 | -0.60 | -1.82 |
| Calculated EPS (Adj) (Unit Curr.) | -0.90 | -0.66 | -0.53 | -0.84 | -0.60 | -1.82 |
| Calculated EPS (Ann.) (Unit Curr.) | -3.59 | -2.65 | -2.13 | -3.36 | -2.41 | -7.29 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -3.59 | -2.65 | -2.13 | -3.36 | -2.41 | -7.29 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -6.22 | -1.00 | 7.40 | -0.53 | -3.43 | -44.93 |
| PBDTM(%) | -14.79 | -3.90 | 0.89 | -1.78 | -5.10 | -45.94 |
| PATM(%) | -39.92 | -30.66 | -19.57 | -20.36 | -22.52 | -61.32 |